250 PHILLIPS BOULEVARD, EWING, NJ
Financial Results, Press Release
2026 Annual Meeting Results; Directors Elected with Majority Votes
Announces First Quarter 2026 Financial Results
Annual Report to Security Holders
Announces Third Quarter 2025 Financial Results, To Acquire Emissive OLED Patent Assets from Merck KGaA, Darmstadt, Germany
Announces Second Quarter 2025 Financial Results
Shareholder votes
Q2
Q1
FY 2024
Q3
FY 2023
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(3)
Prospectus filed pursuant to Rule 424(b)(5)
Prospectus Filed Pursuant to Rule 424(b)(2)
S-3ASR
Additional Proxy Materials
Definitive Proxy Statement
Statement of Changes in Beneficial Ownership
Submission Upload
Correspondence
Confidential Treatment Order